ArticleEClinicalMedicine2022

PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.

Drissa Coulibaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.